Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/ Metastatic Cervical Cancer
Clinical trial NCT07627620 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07627620
- Sponsor
- Hunan Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2027-09-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.